Tofacitinib in new-onset PMR: Nice mechanistic data - all the right things line up - leading to promising proof-of-concept study (EAST PMR) Plenty to tease apart here but real promise to explore in bigger studies ABST1107 #ACR22 @RheumNow https://t.co/s4ts7lrVtZ